Escitalopram-related rhabdomyolysis

Journal of Clinical Psychopharmacology

Volumn 31, Issue 2, 2011, Pages 251-253

  Lewien, Antje ^a   Kranaster, Laura ^a   Hoyer, Carolin ^a   Elkin, Hasan ^a   Sartorius, Alexander ^a  

^a CENTRAL INSTITUTE OF MENTAL HEALTH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; ESCITALOPRAM; LOW DENSITY LIPOPROTEIN;

ADULT; BEHAVIOR DISORDER; CASE REPORT; CHOLESTEROL BLOOD LEVEL; CLINICAL FEATURE; CREATINE KINASE BLOOD LEVEL; DRUG BLOOD LEVEL; DRUG INDUCED DISEASE; DRUG WITHDRAWAL; FLUID THERAPY; HUMAN; LETTER; LIBIDO DISORDER; LOW DRUG DOSE; MAJOR DEPRESSION; MALE; MEDICAL HISTORY; MOOD DISORDER; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RHABDOMYOLYSIS; SIDE EFFECT; SLEEP DISORDER; SUICIDAL IDEATION; TREATMENT RESPONSE;

ADULT; CITALOPRAM; DEPRESSIVE DISORDER, MAJOR; HUMANS; MALE; RHABDOMYOLYSIS;

EID: 79952414064     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/JCP.0b013e31820f4f84     Document Type: Letter

References (12)

1. Vari G, Beckson M. Escitalopram-associated serotonin toxicity. J Clin Psychopharmacol. 2007;27(2):229-230.
2. Huska MT, Catalano G, Catalano MC. Serotonin syndrome associated with the use of escitalopram. CNS Spectr. 2007;12(4):270-274. (Pubitemid 46717319)
3. Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med. 2005;352(11): 1112-1120.
4. Grundemar L,Wohlfart B, Lagerstedt C, et al. Symptoms and signs of severe citalopram overdose. Lancet. 1997;349(9065):1602. (Pubitemid 27229145)
5. Richards S, Umbreit JN, Fanucchi MP, et al. Selective serotonin reuptake inhibitorYinduced rhabdomyolysis associated with irinotecan. South Med J. 2003;96(10):1031-1033. (Pubitemid 38281674)
6. Gareri P, Segura-Garcia C, De Fazio P, et al. Sertraline-induced rhabdomyolysis in an elderly patient with dementia and comorbidities. Ann Pharmacother. 2009;43(7):1354-1359.
7. Peano C, Leikin JB, Hanashiro PK. Seizures, ventricular tachycardia, and rhabdomyolysis as a result of ingestion of venlafaxine and lamotrigine. Ann Emerg Med. 1997;30(5):704-708. (Pubitemid 27469183)
8. Pascale P, Oddo M, Pacher P, et al. Severe rhabdomyolysis following venlafaxine overdose. Ther Drug Monit. 2005;27(5): 562-564. (Pubitemid 41437631)
9. Kuliwaba A. Non-lethal mirtazapine overdose with rhabdomyolysis. Aust N Z J Psychiatry. 2005;39(4):312-313.
10. David D, Esquenazi J. Rhabdomyolysis associated with bupropion treatment. J Clin Psychopharmacol. 1999;19(2):185-186.
11. Bobé F, Buil ME, Palacios L. Rhabdomyolysis connected with the use of bupropion. Scand J Prim Health Care. 2004;22(3):191-192.
12. Wilson AD, Howell C, Waring WS. Venlafaxine ingestion is associated with rhabdomyolysis in adults: a case series. J Toxicol Sci. 2007;32(1):97-101. (Pubitemid 46334074)